Wijngaard Peter's Form 4 filing
Hepion Pharmaceuticals, Inc. (HEPA) · filed Sep 20, 2023
- Accession no.
- 0001104659-23-102209
- Filed
- Sep 20, 2023
- Trade date
- Sep 15-19, 2023
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $16.8K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wijngaard PeterCIK 0001778501 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2023 | Common Stock | PPurchaseAcquired | +1,000 | $5.82 | +$5,820 | 2,501 | Direct | |
| Sep 15, 2023 | Common Stock | PPurchaseAcquired | +139 | $5.45 | +$757.55 | 2,640 | Direct | |
| Sep 15, 2023 | Common Stock | PPurchaseAcquired | +861 | $5.37 | +$4,623.57 | 3,501 | Direct | |
| Sep 19, 2023 | Common Stock | PPurchaseAcquired | +1,000 | $5.64 | +$5,640 | 4,501 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.